151 related articles for article (PubMed ID: 10362136)
61. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
62. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
Hendricks DT; Taylor R; Reed M; Birrer MJ
Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105
[TBL] [Abstract][Full Text] [Related]
63. Significance of FHIT expression in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; O'Brien S; Manshouri T; Cortes J; Giles F; Rios MB; Croce CM; Albitar M
Clin Cancer Res; 1999 Dec; 5(12):4059-64. PubMed ID: 10632340
[TBL] [Abstract][Full Text] [Related]
64. FHIT mRNA expression in thymoma.
Sasaki H; Yukiue H; Kobayashi Y; Yano M; Fukai I; Fujii Y
Eur J Surg Oncol; 2003 Dec; 29(10):904-7. PubMed ID: 14624786
[TBL] [Abstract][Full Text] [Related]
65. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
66. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM
Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370
[TBL] [Abstract][Full Text] [Related]
67. Alterations of the FHIT gene in human hepatocellular carcinoma.
Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
[TBL] [Abstract][Full Text] [Related]
68. Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines.
Hiraoka H; Minami K; Kaneko N; Shimokawa Miyama T; Okamura Y; Mizuno T; Okuda M
J Vet Med Sci; 2009 Jun; 71(6):769-77. PubMed ID: 19578286
[TBL] [Abstract][Full Text] [Related]
69. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
70. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
71. Aberrant FHIT transcripts in human colorectal cancers.
Lee SH; Lee SH
Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
[TBL] [Abstract][Full Text] [Related]
72. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
73. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue.
Tokuchi Y; Kobayashi Y; Hayashi S; Hayashi M; Tanimoto K; Hashimoto T; Nishida K; Ishikawa Y; Nakagawa K; Satoh Y; Yamamoto M; Tsuchiya E
Genes Chromosomes Cancer; 1999 Feb; 24(2):105-11. PubMed ID: 9885976
[TBL] [Abstract][Full Text] [Related]
74. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
Rouer E; Dreyfus F; Melle J; Benarous R
Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
[TBL] [Abstract][Full Text] [Related]
75. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
76. Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.
Kowara R; Gołebiowski F; Chrzan P; Skokowski J; Karmolinski A; Pawełczyk T
Acta Biochim Pol; 2002; 49(2):341-50. PubMed ID: 12362975
[TBL] [Abstract][Full Text] [Related]
77. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE
Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912
[TBL] [Abstract][Full Text] [Related]
78. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
[TBL] [Abstract][Full Text] [Related]
79. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
80. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]